{"id":"https://openalex.org/W1973199191","doi":"https://doi.org/10.1097/mbc.0000000000000147","title":"Impact of nonsynonymous mutations of factor X on the functions of factor X and anticoagulant activity of edoxaban","display_name":"Impact of nonsynonymous mutations of factor X on the functions of factor X and anticoagulant activity of edoxaban","publication_year":2014,"publication_date":"2014-06-07","ids":{"openalex":"https://openalex.org/W1973199191","doi":"https://doi.org/10.1097/mbc.0000000000000147","mag":"1973199191","pmid":"https://pubmed.ncbi.nlm.nih.gov/24911450"},"language":"en","primary_location":{"id":"doi:10.1097/mbc.0000000000000147","doi":"https://doi.org/10.1097/mbc.0000000000000147","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mbc.0000000000000147","pdf_url":null,"source":{"id":"https://openalex.org/S118812467","display_name":"Blood Coagulation & Fibrinolysis","issn_l":"0957-5235","issn":["0957-5235","1473-5733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Coagulation & Fibrinolysis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027684346","display_name":"Kengo Noguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]},{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kengo Noguchi","raw_affiliation_strings":["aThe Keio-Daiichi Project on Genetics of Thrombosis, Keio University bBiological Research Laboratories cNew Drug Regulatory Affairs Department dResearch Oversight Function, R&D Division, Daiichi Sankyo Co., Ltd eLaboratory Medicine, Keio University School of Medicine, Tokyo, Japan","Biological Research Laboratories","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aThe Keio-Daiichi Project on Genetics of Thrombosis, Keio University bBiological Research Laboratories cNew Drug Regulatory Affairs Department dResearch Oversight Function, R&D Division, Daiichi Sankyo Co., Ltd eLaboratory Medicine, Keio University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103","https://openalex.org/I4210104626"]},{"raw_affiliation_string":"Biological Research Laboratories","institution_ids":[]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072163593","display_name":"Yoshiyuki MORISHIMA","orcid":"https://orcid.org/0000-0002-5062-1134","observed_orcids":["https://orcid.org/0000-0002-5062-1134"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Morishima","raw_affiliation_strings":["Biological Research Laboratories","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Research Laboratories","institution_ids":[]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023266965","display_name":"Shinichi Takahashi","orcid":"https://orcid.org/0000-0002-0903-3891","observed_orcids":["https://orcid.org/0000-0002-0903-3891"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichi Takahashi","raw_affiliation_strings":["Biological Research Laboratories","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Research Laboratories","institution_ids":[]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102399355","display_name":"Hiroaki Ishihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Ishihara","raw_affiliation_strings":["New Drug Regulatory Affairs Department","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Drug Regulatory Affairs Department","institution_ids":[]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018542798","display_name":"Toshiro Shibano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]},{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiro Shibano","raw_affiliation_strings":["Research Oversight Function, R&D Division, Daiichi Sankyo Co., Ltd","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Oversight Function, R&D Division, Daiichi Sankyo Co., Ltd","institution_ids":["https://openalex.org/I4210104626"]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074124307","display_name":"Mitsuru Murata","orcid":"https://orcid.org/0000-0002-2728-6198","observed_orcids":["https://orcid.org/0000-0002-2728-6198"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuru Murata","raw_affiliation_strings":["Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan","The Keio-Daiichi Project on Genetics of Thrombosis, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"The Keio-Daiichi Project on Genetics of Thrombosis, Keio University","institution_ids":["https://openalex.org/I203951103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027684346"],"corresponding_institution_ids":["https://openalex.org/I203951103","https://openalex.org/I4210104626"],"apc_list":null,"apc_paid":null,"fwci":0.4729,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.67550844,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"26","issue":"2","first_page":"117","last_page":"122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.028599999845027924,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":0.972000002861023},{"id":"https://openalex.org/keywords/factor-x","display_name":"factor X","score":0.9259999990463257},{"id":"https://openalex.org/keywords/non-synonymous-single-nucleotide-polymorphisms","display_name":"non-synonymous single nucleotide polymorphisms","score":0.8659999966621399},{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/anticoagulant-activity","display_name":"anticoagulant activity","score":0.7910000085830688},{"id":"https://openalex.org/keywords/food-drug-interactions","display_name":"food-drug interactions","score":0.37299999594688416},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9399999976158142},{"id":"https://openalex.org/keywords/michaelis-menten-kinetics","display_name":"Michaelis-Menten kinetics","score":0.7490000128746033},{"id":"https://openalex.org/keywords/prothrombin-time","display_name":"prothrombin time","score":0.7889999747276306},{"id":"https://openalex.org/keywords/activated-partial-thrombin-time","display_name":"activated partial thrombin time","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.6809999942779541},{"id":"https://openalex.org/keywords/genetic-variation","display_name":"genetic variation","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.9910041689872742},{"id":"https://openalex.org/C149904235","wikidata":"https://www.wikidata.org/wiki/Q7049620","display_name":"Nonsynonymous substitution","level":4,"score":0.7264665365219116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6675840020179749},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.427884578704834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36082836985588074},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.34114038944244385},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.24249210953712463},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17431104183197021},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.142342209815979},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.10128971934318542},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.0},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005170","descriptor_name":"Factor X","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005170","descriptor_name":"Factor X","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mbc.0000000000000147","doi":"https://doi.org/10.1097/mbc.0000000000000147","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mbc.0000000000000147","pdf_url":null,"source":{"id":"https://openalex.org/S118812467","display_name":"Blood Coagulation & Fibrinolysis","issn_l":"0957-5235","issn":["0957-5235","1473-5733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Coagulation & Fibrinolysis","raw_type":"journal-article"},{"id":"pmid:24911450","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24911450","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6602999222","display_name":"Comprehensive analysis of novel monitoring markers of anticoagulation and antiplatelet therapies","funder_award_id":"23249030","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320317814","display_name":"Sysmex Corporation","ror":"https://ror.org/00gfstq19"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W62994428","https://openalex.org/W1515782956","https://openalex.org/W1866866972","https://openalex.org/W1974709342","https://openalex.org/W1985059672","https://openalex.org/W1987761929","https://openalex.org/W1997637512","https://openalex.org/W2002893321","https://openalex.org/W2004470519","https://openalex.org/W2027151097","https://openalex.org/W2027588198","https://openalex.org/W2027735039","https://openalex.org/W2031440782","https://openalex.org/W2041349540","https://openalex.org/W2059758858","https://openalex.org/W2088710403","https://openalex.org/W2101862120","https://openalex.org/W2110173126","https://openalex.org/W2123446579","https://openalex.org/W2124693396","https://openalex.org/W2127385343","https://openalex.org/W2127787916","https://openalex.org/W2137422676","https://openalex.org/W2146239526","https://openalex.org/W2150666115","https://openalex.org/W2167633411","https://openalex.org/W4214923018","https://openalex.org/W6631699665"],"related_works":["https://openalex.org/W2980200609","https://openalex.org/W2894712992","https://openalex.org/W4256422570","https://openalex.org/W2046261481","https://openalex.org/W3117907842","https://openalex.org/W1967129589","https://openalex.org/W2124693396","https://openalex.org/W2134234631","https://openalex.org/W2167656313","https://openalex.org/W2561387155"],"abstract_inverted_index":{"Edoxaban":[0],"is":[1,16,36,43],"an":[2,13],"oral":[3,14],"direct":[4],"factor":[5,50,71,78,90,238],"Xa":[6],"(FXa)":[7],"inhibitor":[8],"and":[9,21,80,93,107,119,128,135,148,158,162,179,190,199,207],"its":[10],"efficacy":[11],"as":[12,97],"anticoagulant":[15],"less":[17],"subject":[18],"to":[19,60,196],"drug-food":[20],"drug-drug":[22],"interaction":[23],"than":[24],"existing":[25],"vitamin":[26],"K":[27],"antagonists.":[28],"Although":[29],"this":[30],"profile":[31],"of":[32,49,55,65,77,83,105,110,116,141,150,155,185,193,220],"edoxaban":[33,186,194,228],"suggests":[34],"it":[35,42],"well":[37],"suited":[38],"for":[39,187],"clinical":[40],"use,":[41],"not":[44,165,174,202],"clear":[45],"whether":[46],"genetic":[47],"variations":[48],"X":[51,72,79,239],"influence":[52],"the":[53,70,75,81,103,108,146,176,188,191,218,237],"activity":[54,82,109,219],"edoxaban.":[56,84,111,151,221],"Our":[57],"aim":[58],"was":[59],"investigate":[61],"a":[62,123],"possible":[63,98],"impact":[64,216],"single-nucleotide":[66],"polymorphisms":[67],"(SNPs)":[68],"in":[69,122,145,236],"gene":[73],"on":[74,217],"functions":[76,104],"Two":[85],"nonsynonymous":[86],"SNPs":[87,235],"within":[88],"mature":[89],"X,":[91],"Ala152Thr":[92],"Gly192Arg,":[94],"were":[95,164,201],"selected":[96],"candidates":[99],"that":[100,211,227],"might":[101],"affect":[102,175],"FXa":[106,177],"We":[112],"measured":[113],"catalytic":[114,178],"activities":[115],"wild":[117,205],"type":[118,206],"mutant":[120],"FXas":[121,189,209],"chromogenic":[124],"assay":[125],"using":[126],"S-2222":[127],"coagulation":[129,180],"times":[130],"including":[131],"prothrombin":[132],"time":[133,139],"(PT)":[134],"activated":[136],"partial":[137],"thrombin":[138],"(aPTT)":[140],"plasma-containing":[142],"recombinant":[143],"FXs":[144],"presence":[147],"absence":[149],"Michaelis-Menten":[152],"kinetic":[153],"parameters":[154],"FXas,":[156],"Km":[157],"Vmax":[159],"values,":[160],"PT":[161,198],"aPTT":[163,200],"influenced":[166],"by":[167],"either":[168],"mutation":[169],"indicating":[170,210],"these":[171,224],"mutations":[172,213],"do":[173],"activities.":[181],"The":[182],"Ki":[183],"values":[184],"concentrations":[192],"required":[195],"double":[197],"different":[203],"between":[204],"mutated":[208],"both":[212],"have":[214],"little":[215,230],"In":[222],"conclusion,":[223],"data":[225],"suggest":[226],"has":[229],"interpatient":[231],"variability":[232],"stemming":[233],"from":[234],"gene.":[240]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}